Testing effectiveness (Phase 2)Study completedNCT02168686
What this trial is testing
Safety Dose Finding Study of ADVM-043 Gene Therapy to Treat Alpha-1 Antitrypsin (A1AT) Deficiency
Who this might be right for
Alpha 1-Antitrypsin Deficiency
Adverum Biotechnologies, Inc. 6